share_log

Avecho Biotechnology Ltd: AVE receives final ethics approval for Phase III CBD trial

Mar 7 06:31
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.